SCHEDULE 13G/A 0001140361-25-026782 0002050526 XXXXXXXX LIVE 2 Common Stock, par value $0.0001 per share 09/30/2025 0001533998 DarioHealth Corp. 23725P209 322 W. 57th Street, # 33B New York NY 10019 Rule 13d-1(c) Titan Trust 2024 I b DE 0 0 0 0 0 N 0 OO Row 5, Row 7 and Row 9 reflect the disposition, during the three months ended September 30, 2025, of 100% of 2,499,618 shares* of common stock of the issuer issued to the Reporting Person on August 14, 2025 upon cashless exercise of a third warrant dated February 15, 2024. *The number of shares represents pre- 20-to1 reverse stock split, which was implemented by the Issuer on August 28, 2025. DarioHealth Corp. 322 W. 57th Street, # 33B, New York, New York, 10019 Titan Trust 2024 I c/o WhiteHawk Capital Partners LP, as Administrator 11601 Wilshire Blvd., Suite 1980, Los Angeles, CA, 90025 Titan Trust 2024 I is a Delaware statutory trust organized under the laws of the State of Delaware. Y 0 0 0 0 0 0 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Titan Trust 2024 I By: WhiteHawk Capital Partners LP, its Administrator /s/ Robert Louzan 10/09/2025